Structured evidence table for Nac Respiratory Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Nac Respiratory Meta-Analysis | Although cigarette smoking and exposure to air contaminants are the most important risk factors, oxidative stress (OS) has also been identified as an important mechanism in COPD development, progression, and exacerbations [,]. | 1 | López-Denis Manuel (2026) | Antioxidants as Therapeutic Tools in the Management of COPD: A Systematic Review with Meta-Analysis |
| Nac Respiratory Meta-Analysis | In these patients, lung epithelial and endothelial cells also produce increased ROS levels. | 1 | López-Denis Manuel (2026) | Antioxidants as Therapeutic Tools in the Management of COPD: A Systematic Review with Meta-Analysis |
| Nac Respiratory Meta-Analysis | OS contributes not only to chronic inflammation but also to increased resistance to corticosteroid therapies, accelerated senescence, and diminished tissue repair capacity, thereby accelerating the decline in lung function typical of the disease [,]. | 1 | López-Denis Manuel (2026) | Antioxidants as Therapeutic Tools in the Management of COPD: A Systematic Review with Meta-Analysis |
| Nac Respiratory Meta-Analysis | 1 2 3 4 3 3 4 5 6 7 Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease characterized by persistent limitation to air flux and chronic respiratory inflammation leading to progressive loss of lung function. | 1 | López-Denis Manuel (2026) | Antioxidants as Therapeutic Tools in the Management of COPD: A Systematic Review with Meta-Analysis |
| Nac Respiratory Meta-Analysis | Despite robust evidence, NAC remains underutilized; greater clinical integration requires clearer guideline recommendations and clinician awareness. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
| Nac Respiratory Meta-Analysis | This review consolidates current evidence and expert consensus on NAC for clinical reference. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
| Nac Respiratory Meta-Analysis | This reduces mucus viscosity and facilitates improved mucociliary clearance.Anti-inflammatory effect of NAC: NAC modulates NF-κB signaling and scavenges reactive oxygen species (ROS), reducing inflammatory activation. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
| Nac Respiratory Meta-Analysis | 1 2 Figure 1 3 4 5 6 7 12 N-acetylcysteine (NAC), an acetylated derivative of L-cysteine, serves as a precursor of glutathione (GSH), a key pulmonary antioxidant. | 2 | Barne Monica (2026) | N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) |
Source documents